These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9154073)

  • 1. Therapies for advanced colorectal cancer: the role of interferon and leucovorin.
    Macdonald JS
    Tumori; 1997; 83(1 Suppl):S67-9. PubMed ID: 9154073
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer.
    Vermeulen PB; Dirix LY; Pelgrims G; Van Oosterom AT
    Cancer; 1995 Aug; 76(3):528-30. PubMed ID: 8625138
    [No Abstract]   [Full Text] [Related]  

  • 3. How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.
    Ragnhammar P; Blomgren H
    Med Oncol; 1995 Sep; 12(3):187-201. PubMed ID: 8852401
    [No Abstract]   [Full Text] [Related]  

  • 4. [Irinotecan plus fluorouracil and folinic acid in metastatic colorectal cancer].
    Krieger G
    Strahlenther Onkol; 2001 Jun; 177(6):316-8. PubMed ID: 11446323
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of oral chemotherapy in colorectal cancer.
    Donehower RC
    Oncology (Williston Park); 2000 Nov; 14(11A):243-5. PubMed ID: 11195416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results.
    Benson AB
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):28-34. PubMed ID: 9830622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer.
    Sandor V
    Lancet; 1997 Nov; 350(9087):1325-6. PubMed ID: 9357429
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antineoplastic chemotherapy in digestive tumors].
    Bellmunt J; Albanell J; Gallego OS; Vicente P
    Med Clin (Barc); 1991 Sep; 97(9):358. PubMed ID: 1720494
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gleaning from the American Oncology Congress. A new standard in colorectal carcinoma].
    MMW Fortschr Med; 2002 Oct; 144(41):61. PubMed ID: 12474374
    [No Abstract]   [Full Text] [Related]  

  • 10. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
    Chen ML; Fang CH; Liang LS; Dai LH; Wang XK
    Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of interferon-alpha as a modulator of fluorouracil and leucovorin.
    Grem JL; van Groeningen CJ; Ismail AA; Johnston PG; Alexander HR; Allegra CJ
    Eur J Cancer; 1995; 31A(7-8):1316-20. PubMed ID: 7577043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.
    Ledermann JA; Leonard P; Seymour M
    N Engl J Med; 2001 Jul; 345(2):145-6. PubMed ID: 11450667
    [No Abstract]   [Full Text] [Related]  

  • 13. Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.
    Chang DZ; Abbruzzese JL
    Clin Adv Hematol Oncol; 2005 May; 3(5):400-4. PubMed ID: 16167013
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adjuvant chemotherapy for colorectal carcinoma after curative resection].
    Murakami M; Tsukuda K; Ota T; Naito M; Shimizu N
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():449-53. PubMed ID: 14574933
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of a European multicentre trial of Tomudex versus 5-FU/high dose LV (Machover regimen).
    Cocconi G
    Tumori; 1997; 83(1 Suppl):S72. PubMed ID: 9154075
    [No Abstract]   [Full Text] [Related]  

  • 16. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
    Gambill BD
    Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
    [No Abstract]   [Full Text] [Related]  

  • 17. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Erlichman C; Goldberg RM; O'Connell MJ
    N Engl J Med; 2001 Jan; 344(4):305; author reply 306-7. PubMed ID: 11191661
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer.
    Underhill C; Goldstein D; Gorbounova VA; Biakhov MY; Bazin IS; Granov DA; Hossain AM; Blatter J; Kaiser C; Ma D
    Oncology; 2007; 73(1-2):9-20. PubMed ID: 18334829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in administration of 5-fluorouracil and folinic acid in standard treatment regimens for advanced colorectal cancer.
    Zalcberg JR; Harsley SR; Dooley MJ
    Intern Med J; 2002 Dec; 32(12):610-3. PubMed ID: 12512755
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomodulation of 5-fluorouracil with antifolates.
    Bertino JR
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-52-S18-56. PubMed ID: 9420021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.